New implant study tracks Real-World results for rheumatoid arthritis patients
Disease control
Not yet recruiting
This study follows 150 adults with moderate-to-severe rheumatoid arthritis who have received the SetPoint System, an implanted device that uses nerve stimulation to control inflammation. Researchers will monitor device safety, ease of use, and how well it controls disease activit…
Sponsor: SetPoint Medical Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC